Literature DB >> 35981000

Beyond Diagnosis: a Novel Microbiota Dependent Biomarker and Target for Atherosclerosis.

Di Lang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35981000      PMCID： PMC9395143          DOI： 10.1161/CIRCRESAHA.122.321641

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   23.213


× No keyword cloud information.
  15 in total

1.  Acute and stable coronary heart disease: different risk factors.

Authors:  Stefan Agewall
Journal:  Eur Heart J       Date:  2008-07-10       Impact factor: 29.983

2.  Gut microbiota, the genome, and diet in atherogenesis.

Authors:  Joseph Loscalzo
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

3.  MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer.

Authors:  Zhao Wang; Zhimin Liu; Xiaojie Fang; Han Yang
Journal:  Cell Physiol Biochem       Date:  2017-10-31

Review 4.  The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

5.  Proteomic and metabolomic analyses reveal the full spectrum of inflammatory and lipid metabolic abnormalities in dyslipidemia.

Authors:  Hui Du; Yifei Rao; Ronghua Liu; Kesui Deng; Yongmei Guan; Dewei Luo; Qiping Mao; Jianwei Yu; Tao Bo; Ziquan Fan; Hui Ouyang; Yulin Feng; Weifeng Zhu
Journal:  Biomed Chromatogr       Date:  2021-05-31       Impact factor: 1.902

6.  Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease.

Authors:  Hongliang Xue; Xu Chen; Chao Yu; Yuqing Deng; Yuan Zhang; Shen Chen; Xuechen Chen; Ke Chen; Yan Yang; Wenhua Ling
Journal:  Circ Res       Date:  2022-07-27       Impact factor: 23.213

7.  miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program.

Authors:  Shicheng Su; Qiyi Zhao; Chonghua He; Di Huang; Jiang Liu; Fei Chen; Jianing Chen; Jian-You Liao; Xiuying Cui; Yunjie Zeng; Herui Yao; Fengxi Su; Qiang Liu; Shanping Jiang; Erwei Song
Journal:  Nat Commun       Date:  2015-10-05       Impact factor: 14.919

8.  Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.

Authors:  Vanessa D de Mello; Jussi Paananen; Jaana Lindström; Maria A Lankinen; Lin Shi; Johanna Kuusisto; Jussi Pihlajamäki; Seppo Auriola; Marko Lehtonen; Olov Rolandsson; Ingvar A Bergdahl; Elise Nordin; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Rikard Landberg; Johan G Eriksson; Jaakko Tuomilehto; Kati Hanhineva; Matti Uusitupa
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

Review 9.  Microbial tryptophan catabolites in health and disease.

Authors:  Henrik M Roager; Tine R Licht
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

Review 10.  Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.

Authors:  Gabriele Giacomo Schiattarella; Anna Sannino; Evelina Toscano; Giuseppe Giugliano; Giuseppe Gargiulo; Anna Franzone; Bruno Trimarco; Giovanni Esposito; Cinzia Perrino
Journal:  Eur Heart J       Date:  2017-10-14       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.